67684 Federal Register / Vol. 62, No. 248 / Monday, December 29, 1997 / Notices

SUPPLEMENTARY INFORMATION: The

Chairman of the TPSC invites written

comments from the public on the

expansion of the list of pharmaceutical

products receiving duty-free treatment

from certain members of the World

Trade Organization, specifically

additions to the lists of pharmaceutical

active ingredients, prefixes and suffixes

that could be associated with an active

ingredient in order to designate its salt,

ester or hydrate form, or chemical

intermediates intended for the

manufacture of pharmaceutical active

ingredients. Negotiations will take place

during 1998 in the WTO with a view to

adding new pharmaceuticals to the zero

duty list. Any amendments to the list of

pharmaceuticals will be subject to

approval by all participants in the

negotiations.

Background

During the Uruguay Round of

multilateral trade negotiations, the

United States and 16 trading partners

agreed to reciprocal elimination of

duties on approximately 7,000

pharmacuticals on January 1, 1995.

Participants also recognized the need to

periodically update the zero duty list of

pharmaceuticals in order to keep pace

with the dynamic nature of the industry.

As a result of multilateral negotiations

in the World Trade Organization (WTO)

during 1996, the United States and other

participants in the negotiations

eliminated duties on an additional 750

pharmaceuticals on April 1, 1997.

The results of the Uruguay Round

agreement on pharmaceuticals and the

subsequent update by WTO members is

reflected in the Pharmaceutical

Appendix to the Harmonized Tariff

Schedule of the United States (HTSUS).

The HTSUS can be purchased from the

United States Government Printing

Office. An electronic version of HTSUS

can be found at www.usitc.gov. the

Pharmaceutical Appendix of the HTSUS

consists of three tables. Table 1 lists

active pharmaceutical ingredients and

dosage-form products by their

International Nonproprietary Names

(INNs) from the World Heatlh

Organization (WHO). Currently, the

items in Table 1 are drawn from the INN

lists 1–73 of the WHO. Prefixes and

suffixes that can be associated with an

INN in Table 1 are contained in Table

2. Chemical intermediates intended for

the manufacture of pharmaceuticals are

listed in Table 3. Working with

appropriate industry associations and

private sector advisory groups, the

interagency TPSC committee led by

USTR is in the process of preparing

negotiating positions. Comments are

requested for pharmaceutical items

which would be in the interest of the

United States to add to the existing

WTO agreement.

Negotiators will be reviewing the

more recent INN lists (e.g., 74–78) in the

updating exercise. Comments pertaining

to the pharmaceutical active ingredients

covered by INN list 74 and higher need

only provide the INN name and

reference the appropriate WHO list.

Otherwise, the following information

must be supplied for each

pharmaceutical active ingredient or

chemical intermediate to provide the

technical basis for reviewing the

submissions: (1) The precise chemical

name; (2) the Chemical Abstracts

Service (CAS registry number; (3) a

diagram of the molecular structure; and

(4) the six-digit Harmonized System

classification number. Submissions of

chemical intermediates also must

provide the INN and chemical name of

the active ingredient into which it is

incorporated, the CAS number of this

active ingredient, and a diagram of the

molecular structure of this active

ingredient. A suggested format for

presenting this information is attached.

In addition, submissions of chemical

intermediates must demonstrate that the

product meets the following conditions;

(1) The chemical is a solepharmaceutical use intermediate; (2)

some portion of the intermediate is

incorporated in the final active

ingredient molecule, regardless of what

proportion the intermediate represents

in the final molecule of the active

ingredient; and (3) the intermediate is

used in producing an active ingredient

that has reached at least Phase III of

clinical trials of the Food and Drug

Administration (or other national

equivalent). Comments pertaining to the

additions to the list of prefixes or

suffixes for salt, ester or hydrate forms

of an INN active ingredient should state

a rationale for the nomination. Only

comments containing all of the above

information will be considered in

developing U.S. positions for the

negotiations.

Persons submitting written comments

should provide a statement, in twenty

copies, by noon, January 30, 1998 to

Gloria Blue, Executive Secretary, TPSC,

Office of the U.S. Trade Representative,

Room 503, 600 17th Street, NW.,

Washington, D.C. 20508. In addition, a

helpful supplement to the written

statement would be to provide a disk

containing as much of the technical

details of the submission as possible,

either in a spreadsheet format or in a

word processing table format. The disk

should have a label identifying the

software used and the submitter. Nonconfidential information received will

be available for public inspection by

appointment in the USTR Reading

Room, Room 101, Monday through

Friday, 10:00 a.m. to 12:00 noon and

1:00 p.m. to 4:00 p.m. For an

appointment call Brenda Webb on 202–

395–6186. Business confidential

information will be subject to the

requirements of 15 CFR 2003.6. Any

business confidential material must be

clearly marked as such on the cover

letter or page and each succeeding page,

and must be accompanied by a nonconfidential summary thereof.

Frederick L. Montgomery,

Chairman, Trade Policy Staff Committee.

HS code (6-

digit) CAS number

Chemical

name (e.g.,

chemical abstracts index

name

Molecular structure

For all chemical intermediates, the

following information is provided on

the pharmaceutical active ingredient

into which the intermediate is

incorporated.

INN of active

ingredient

CAS number

of active ingredient

Chemical

name of active ingredient

Molecular structure of active ingredient

[FR Doc. 97–33751 Filed 12–24–97; 8:45 am]

BILLING CODE 3190–01–M

DEPARTMENT OF TRANSPORTATION

Office of the Secretary

Reports, Forms and Recordkeeping

Requirements; Agency Information

Collection Activity Under OMB Review

AGENCY: Office of the Secretary, DOT.

ACTION: Notice.

SUMMARY: In accordance with the

Paperwork Reduction Act of 1995 (44

U.S.C. Chapter 3501, et seq.) this notice

announces that the Information

Collection Request (ICR) abstracted

below has been forwarded to the Office

of Management and Budget (OMB) for

review and comment. The ICR describes

the nature of the information collection

and its expected cost and burden. The

Federal Register Notice with a 60-day

comment period soliciting comments on

the following collection of information
Federal Register / Vol. 62, No. 248 / Monday, December 29, 1997 / Notices 67685

was published in 62 FR 52611, October

8, 1997.

DATES: Comments on this notice must be

received on or before January 28, 1998.

FOR FURTHER INFORMATION CONTACT:

Carol A. Woods, Air Carrier Fitness,

Office of Aviation Analysis, Office of

the Secretary, U.S. Department of

Transportation, 400 Seventh St. SW.,

Washington, DC 20590 at (202) 366–

2340.

SUPPLEMENTARY INFORMATION: Office of

the Secretary.

Title: Aircraft Accident Liability

Insurance.

OMB Control Number: 2106–0030

Affected Public: U.S. and foreign air

carriers.

Type of Request: Extension of a

previously approved collection.

Form(s): OST Form 6410, OST Form

6411.

Abstract: 14 CFR Part 205 contains

the minimum requirements for air

carrier accident liability insurance to

protect the public from losses, and

directs that certificates evidencing

appropriate coverage must be filed with

the Department.

Estimated Annual Burden Hours:

2,763 hours.

Send comments to the Office of

Information and Regulatory Affairs,

Office of Management and Budget, 725–

17th Street, NW., Washington, DC

20503, Attention DOT Desk Officer.

Comments are invited on: Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the Department,

including whether the information will

have practical utility; the accuracy of

the Department’s estimate of the burden

of the proposed information collection;

ways to enhance the quality, utility and

clarity of the information to be

collected; and ways to minimize the

burden of the collection of information

on respondents, including the use of

automated collection techniques or

other forms of information technology.

Comments to OMB are best assured of

having their full effect if OMB receives

them within 30 days of publication.

Issued in Washington, DC, on December

18, 1997.

Phillip A. Leach,

Clearance Officer, United States Department

of Transportation.

[FR Doc. 97–33689 Filed 12–24–97; 8:45 am]

BILLING CODE 4910–62–P

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Executive Committee of the Aviation

Rulemaking Advisory Committee;

Meeting

AGENCY: Federal Aviation

Administration (FAA), DOT.

ACTION: Notice of meeting.

SUMMARY: The FAA is issuing this notice

to advise the public of a meeting of the

Executive Committee of the Federal

Aviation Administration Aviation

Rulemaking Advisory Committee.

DATES: The meeting will be held on

January 8, 1998, at 1 p.m.

ADDRESSES: The meeting will be held at

the Federal Aviation Administration,

800 Independence Avenue, SW., Room

810, Washington, DC.

FOR FURTHER INFORMATION CONTACT:

Miss Jean Casciano, Federal Aviation

Administration, 800 Independence

Avenue, SW., Washington, DC 20591,

telephone (202) 267–9683; fax (202)

267–5075; e-mail

Jean.Casciano@faa.dot.gov.

SUPPLEMENTARY INFORMATION: Pursuant

to section 10(a)(2) of the Federal

Advisory Committee Act (Pub. L. 92–

463; 5 U.S.C. App. II), notice is hereby

given of a meeting of the Executive

Committee to be held on January 8,

1998, at the Federal Aviation

Administration, 800 Independence

Avenue, SW., Room 810, Washington,

DC, 1 p.m. The purpose of the meeting

is to review and discuss a proposed new

task—Prevention of Fuel Tank

Explosions.

Attendance is open to the interested

public but will be limited to the space

available. The public may participate by

teleconference by calling 202–493–4180,

pass code 2222. Written statements from

the public may be presented to the

executive committee at any time by

providing 25 copies to the Executive

Director, or by bringing the copies to

him at the meeting.

Sign and oral interpretation can be

made available at the meeting, as well

as an assistive listening device, if

requested 10 calendar days before the

meeting. Arrangements may be made by

contacting the person listed under the

heading FOR FURTHER INFORMATION

CONTACT.

Issued in Washington, DC, on December

22, 1997.

Joseph A. Hawkins,

Executive Director, Aviation Rulemaking

Advisory Committee.

[FR Doc. 97–33861 Filed 12–24–97; 8:45 am]

BILLING CODE 4910–03–M

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Notice of Intent To Rule on Application

To Impose and Use the Revenue From

a Passenger Facility Charge (PFC) at

Akron-Canton Regional Airport, Akron,

OH

AGENCY: Federal Aviation

Administration (FAA), DOT.

ACTION: Notice of intent to rule on

application.

SUMMARY: The FAA proposes to rule and

invites public comment on the

application to impose and use the

revenue from a PFC at Akron-Canton

Regional Airport under the provisions of

the Aviation Safety and Capacity

Expansion Act of 1990 (Title IX of the

Omnibus Budget Reconciliation Act of

1990) (Public Law 101–508) and Part

158 of the Federal Aviation Regulations

(14 CFR Part 158).

DATES: Comments must be received on

or before January 28, 1998.

ADDRESSES: Comments on this

application may be mailed or delivered

in triplicate to the FAA at the following

address: Federal Aviation

Administration, Detroit Airports District

Office, Willow Run Airport, East, 8820

Beck Road, Belleville, Michigan 48111.

In addition, one copy of any

comments submitted to the FAA must

be mailed or delivered to Mr. Frederick

J. Krum, Director of Aviation of the

Akron-Canton Regional Airport

Authority Board at the following

address: Akron-Canton Regional

Airport, 5400 Lauby Road, P.O. Box 9,

North Canton, Ohio 44720–1598.

Air carriers and foreign air carriers

may submit copies of written comments

previously provided to the AkronCanton Regional Airport Authority

Board under section 158.23 of Part 158.

FOR FURTHER INFORMATION CONTACT: Mr.

Lawrence C. King, Program Manager,

Federal Aviation Administration,

Detroit Airports District Office, Willow

Run Airport, East, 8820 Beck Road,

Belleville, Michigan 48111 (313–487–

7293). The application may be reviewed

in person at this same location.

SUPPLEMENTARY INFORMATION: The FAA

proposes to rule and invites public

comment on the application to impose

and use the revenue from a PFC at

Akron-Canton Regional Airport under

the provisions of the Aviation Safety

and Capacity Expansion Act of 1990

(Title IX of the Omnibus Budget

Reconciliation Act of 1990) (Public Law

101–508) and Part 158 of the Federal

Aviation Regulations (14 CFR Part 158).